These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19387990)

  • 1. Pharmacokinetics of nateglinide enantiomers and their metabolites in Goto-Kakizaki rats, a model for type 2 diabetes mellitus.
    Tamura M; Shiba S; Kudo N; Kawashima Y
    Chirality; 2010 Jan; 22(1):92-8. PubMed ID: 19387990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure.
    Inoue T; Shibahara N; Miyagawa K; Itahana R; Izumi M; Nakanishi T; Takamitsu Y
    Clin Nephrol; 2003 Aug; 60(2):90-5. PubMed ID: 12940610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
    Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
    Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of nateglinide in humans.
    Weaver ML; Orwig BA; Rodriguez LC; Graham ED; Chin JA; Shapiro MJ; McLeod JF; Mangold JB
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):415-21. PubMed ID: 11259325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.
    Tentolouris N; Boutati E; Karambakalis N; Perrea D; Tselepis AD; Tsoukala C; Kyriaki D; Lourida E; Anastasopoulou I; Karafoullidou A; Raptis SA; Katsilambros N
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):6-12. PubMed ID: 15871845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
    Mine T; Miura K; Kajioka T; Kitahara Y
    Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nateglinide (Starlix): update on a new antidiabetic agent.
    Phillips LS; Dunning BE
    Int J Clin Pract; 2003; 57(6):535-41. PubMed ID: 12918894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus--a randomized study using positron emission tomography.
    Bengel FM; Abletshauser C; Neverve J; Schnell O; Nekolla SG; Standl E; Schwaiger M
    Diabet Med; 2005 Feb; 22(2):158-63. PubMed ID: 15660732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
    Campbell IW
    Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics of nateglinide in subjects with hepatic cirrhosis.
    Choudhury S; Hirschberg Y; Filipek R; Lasseter K; McLeod JF
    J Clin Pharmacol; 2000 Jun; 40(6):634-40. PubMed ID: 10868314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nateglinide].
    Notoya Y; Kikuchi M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():371-5. PubMed ID: 12387020
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
    Vakkilainen J; Mero N; Schweizer A; Foley JE; Taskinen MR
    Diabetes Metab Res Rev; 2002; 18(6):484-90. PubMed ID: 12469362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
    Tanaka A; Azuma K; Toyofuku Y; Kurokawa A; Otsuka A; Mita T; Hirosea T; Fujitani Y; Miyauchi K; Daida H; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2006 Nov; 350(1):195-201. PubMed ID: 16997277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Van de Voorde J; Rasch R; Lameire NH; Flyvbjerg A
    Nephrol Dial Transplant; 2004 May; 19(5):1092-7. PubMed ID: 14993490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure determination of metabolites isolated from urine and bile after administration of AY4166, a novel D-phenylalanine-derivative hypoglycemic agent.
    Takesada H; Matsuda K; Ohtake R; Mihara R; Ono I; Tanaka K; Naito M; Yatagai M; Suzuki E
    Bioorg Med Chem; 1996 Oct; 4(10):1771-81. PubMed ID: 8931947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a stereoselective HPLC method for the determination of the in vitro transport of nateglinide enantiomers in rat intestine.
    Maddi S; Keshetty S; Mohan Ega C; Yamasani MR; Scriba GK
    J Sep Sci; 2007 Aug; 30(12):1875-80. PubMed ID: 17638349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senaglinide. A 4166, AY 4166, Fastic, SDZ DJN 608, Starlix, Starsis, YM 026, Nateglinide.
    Drugs R D; 1999 Aug; 2(2):123-6. PubMed ID: 10820657
    [No Abstract]   [Full Text] [Related]  

  • 18. No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes.
    Johanson EH; Jansson PA; Gustafson B; Sandqvist M; Taskinen MR; Smith U; Axelsen M
    Diabetes Metab Res Rev; 2005; 21(4):376-81. PubMed ID: 15724236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nateglinide therapy for type 2 diabetes mellitus.
    Levien TL; Baker DE; Campbell RK; White JR
    Ann Pharmacother; 2001 Nov; 35(11):1426-34. PubMed ID: 11724096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes.
    Kitahara Y; Miura K; Takesue K; Mine T; Wada R; Uchida Y; Ito S; Yagihashi S
    Metabolism; 2002 Nov; 51(11):1452-7. PubMed ID: 12404197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.